Picture of Insight Molecular Diagnostics logo

IMDX — Insight Molecular Diagnostics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Marketing Agreement With Thermo Fisher Scientific To Expand Access To Precision Oncology

Jan 18 (Reuters) - Thermo Fisher Scientific Inc  TMO.N :
    * ONCOCYTE ANNOUNCES DEVELOPMENT AND CO-MARKETING AGREEMENT
WITH
THERMO FISHER SCIENTIFIC TO EXPAND ACCESS TO PRECISION ONCOLOGY
    * ONCOCYTE CORP - AGREEMENT ALSO GRANTS ONCOCYTE RIGHTS TO
DEVELOP
FUTURE COMPANION DIAGNOSTICS ON GENEXUS SYSTEM
    * ONCOCYTE CORP - ONCOCYTE WILL CLINICALLY VALIDATE THERMO
FISHER'S EXISTING ONCOMINE COMPREHENSIVE ASSAY PLUS ON GENEXUS
SYSTEM

Source text for Eikon:  ID:nGNX2VvkY5 
Further company coverage:  TMO.N 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Insight Molecular Diagnostics

See all news